Evidence map›Paper›PMID 28003435›Full record

ArticleGenome research2017

Genetic compendium of 1511 human brains available through the UK Medical Research Council Brain Banks Network Resource.

Michael J Keogh, Wei Wei, Ian Wilson, Jon Coxhead, Sarah Ryan, Sara Rollinson, Helen Griffin, Marzena Kurzawa-Akanbi, Mauro Santibanez-Koref, Kevin Talbot and 11 more

Open access · bronzeAbstract read
In one paragraph

Article in Genome research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 2 syntheses or guidelines pooled it, 53 citations in OpenAlex.

  1. Effect of GBA gene variants on clinical characteristics of dementia with Lewy bodies: a review and meta-analyses.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2022
    Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. An Autopsy Series of Seven Cases of VPS13A Disease (Chorea-Acanthocytosis).Movement disorders : official journal of the Movement Disorder Society · 2023
    Article
  6. Article
  7. Somatic mosaicism in the diseased brain.Molecular cytogenetics · 2022
    Review
  8. GRN Mutations Are Associated with Lewy Body Dementia.Movement disorders : official journal of the Movement Disorder Society · 2022
    Article
  9. Article
  10. Article
  11. Isolated homozygous R217XJournal of neurology, neurosurgery, and psychiatry · 2021
    Article
  12. Brain Somatic Mutation in Aging and Alzheimer's Disease.Annual review of genomics and human genetics · 2021
    Review
  13. Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 6 institutions in 1 country.

Michael J KeoghInstitute of Genetic Medicine, Newcastle University, Newcastle Upon Tyne, NE1 3BZ, United Kingdom.
Wei WeiInstitute of Genetic Medicine, Newcastle University, Newcastle Upon Tyne, NE1 3BZ, United Kingdom.
Ian WilsonInstitute of Genetic Medicine, Newcastle University, Newcastle Upon Tyne, NE1 3BZ, United Kingdom.
Jon CoxheadInstitute of Genetic Medicine, Newcastle University, Newcastle Upon Tyne, NE1 3BZ, United Kingdom.
Sarah RyanInstitute of Brain, Behaviour and Mental Health, University of Manchester, Manchester, M13 9PT, United Kingdom.
Sara RollinsonInstitute of Brain, Behaviour and Mental Health, University of Manchester, Manchester, M13 9PT, United Kingdom.
Helen GriffinInstitute of Genetic Medicine, Newcastle University, Newcastle Upon Tyne, NE1 3BZ, United Kingdom.
Marzena Kurzawa-AkanbiInstitute of Genetic Medicine, Newcastle University, Newcastle Upon Tyne, NE1 3BZ, United Kingdom.
Mauro Santibanez-KorefInstitute of Genetic Medicine, Newcastle University, Newcastle Upon Tyne, NE1 3BZ, United Kingdom.
Kevin TalbotDepartment of Clinical Neurosciences, John Radcliffe Hospital, Oxford, OX3 9DU, United Kingdom.
Martin R TurnerDepartment of Clinical Neurosciences, John Radcliffe Hospital, Oxford, OX3 9DU, United Kingdom.
Chris-Anne McKenzieNational CJD Research & Surveillance Unit, Centre for Clinical Brain Sciences, University of Edinburgh, Western General Hospital, Edinburgh, EH4 2XU, United Kingdom.
Claire TroakesDepartment of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, SE5 8AF, United Kingdom.
Johannes AttemsInstitute of Genetic Medicine, Newcastle University, Newcastle Upon Tyne, NE1 3BZ, United Kingdom.
Colin SmithNational CJD Research & Surveillance Unit, Centre for Clinical Brain Sciences, University of Edinburgh, Western General Hospital, Edinburgh, EH4 2XU, United Kingdom.
Safa Al SarrajDepartment of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, SE5 8AF, United Kingdom.
Chris M MorrisInstitute of Genetic Medicine, Newcastle University, Newcastle Upon Tyne, NE1 3BZ, United Kingdom.
Olaf AnsorgeDepartment of Neuropathology, John Radcliffe Hospital, Oxford, OX3 9DU, United Kingdom.
Stuart Pickering-BrownInstitute of Brain, Behaviour and Mental Health, University of Manchester, Manchester, M13 9PT, United Kingdom.
James W IronsideNational CJD Research & Surveillance Unit, Centre for Clinical Brain Sciences, University of Edinburgh, Western General Hospital, Edinburgh, EH4 2XU, United Kingdom.
Patrick F ChinneryDepartment of Clinical Neurosciences, University of Cambridge, Cambridge Biomedical Campus, Cambridge, CB2 0QQ, United Kingdom.
Newcastle University · GBJohn Radcliffe Hospital · GBManchester Academic Health Science Centre · GBUniversity of Cambridge · GBWestern General Hospital · GBKing's College London · GB

Funding

Medical Research Council G0400074Medical Research Council G0502157Medical Research Council G0600953Medical Research Council G0601943Medical Research Council G0900652Medical Research Council G1000691Medical Research Council G1100540Medical Research Council MC_PC_13044Medical Research Council MC_UP_1501/2Medical Research Council MR/K01014X/1Medical Research Council MR/L016400/1Medical Research Council MR/L022656/1Motor Neurone Disease Association TURNER/JAN13/944-795Wellcome TrustWellcome Trust 096919Z/11/ZWellcome Trust 101876/Z/13/Z
6 · The paper itself

Abstract

Given the central role of genetic factors in the pathogenesis of common neurodegenerative disorders, it is critical that mechanistic studies in human tissue are interpreted in a genetically enlightened context. To address this, we performed exome sequencing and copy number variant analysis on 1511 frozen human brains with a diagnosis of Alzheimer's disease (AD, n = 289), frontotemporal dementia/amyotrophic lateral sclerosis (FTD/ALS, n = 252), Creutzfeldt-Jakob disease (CJD, n = 239), Parkinson's disease (PD, n = 39), dementia with Lewy bodies (DLB, n = 58), other neurodegenerative, vascular, or neurogenetic disorders (n = 266), and controls with no significant neuropathology (n = 368). Genomic DNA was extracted from brain tissue in all cases before exome sequencing (Illumina Nextera 62 Mb capture) with variants called by FreeBayes; copy number variant (CNV) analysis (Illumina HumanOmniExpress-12 BeadChip); C9orf72 repeat expansion detection; and APOE genotyping. Established or likely pathogenic heterozygous, compound heterozygous, or homozygous variants, together with the C9orf72 hexanucleotide repeat expansions and a copy number gain of APP, were found in 61 brains. In addition to known risk alleles in 349 brains (23.9% of 1461 undergoing exome sequencing), we saw an association between rare variants in GRN and DLB. Rare CNVs were found in <1.5% of brains, including copy number gains of PRPH that were overrepresented in AD. Clinical, pathological, and genetic data are available, enabling the retrieval of specific frozen brains through the UK Medical Research Council Brain Banks Network. This allows direct access to pathological and control human brain tissue based on an individual's genetic architecture, thus enabling the functional validation of known genetic risk factors and potentially pathogenic alleles identified in future studies.

Indexed as

Alzheimer DiseaseAmyotrophic Lateral SclerosisBiomedical ResearchBrainCreutzfeldt-Jakob SyndromeDNADNA Copy Number VariationsExome SequencingFrontotemporal DementiaGenotypeHumansParkinson DiseaseDNA

Identifiers

PMID28003435
PMCPMC5204341
OpenAlexW2563716679

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.